首页|基于网络药理学分析金花清感颗粒抗炎机制及验证

基于网络药理学分析金花清感颗粒抗炎机制及验证

扫码查看
目的 利用网络药理学和体外细胞试验,研究金花清感颗粒的抗炎活性及机制,为其临床应用提供理论依据.方法 利用TCMSP、Pubchem数据库和相关文献筛选出金花清感颗粒的活性成分及靶标;通过NCBI、GenCards数据库筛选流行性感冒、头痛、发热、咳嗽的关联靶点,并与上述成分-靶点进行比对分析,筛选出核心靶点;采用Cytoscape 3.7.2软件生成药物-关键靶点网络图,最后利用Metascape数据库对核心靶点进行GO、KEGG富集分析.体外细胞试验采用脂多糖(LPS)诱导小鼠单核巨噬细胞RAW264.7炎症细胞模型,采用Griess法检测金花清感颗粒提取物对细胞一氧化氮(NO)分泌的影响;通过实时荧光定量PCR法(qRT-PCR)和Western blotting分别测定金花清感颗粒提取物对RAW264.7细胞中关键靶标的RNA和蛋白水平的影响.结果 数据库筛选后共获得金花清感颗粒活性成分278个,潜在作用靶点1316个,与疾病相关靶点1065个,主要涉及丝裂原活化蛋白激酶(MAPK)信号通路、核因子κB(NF-κB)信号通路及神经活性配体-受体相互作用信号通路等.体外细胞试验结果显示,与LPS 组相比,200,400,800 μg/ml的金花清感颗粒水、醇提物均显著降低LPS诱导的RAW264.7 细胞中NO的分泌量(P<0.01);qRT-PCR检测发现金花清感颗粒提取物能抑制LPS诱导的RAW264.7细胞的诱导型一氧化氮合酶(iNOS),环氧合酶2(COX-2),白介素6(IL-6)mRNA水平(P<0.01);Western blotting检测发现金花清感颗粒提取物能抑制LPS诱导的RAW264.7细胞的iNOS蛋白的表达及NF-κB、MAPK信号通路中关键蛋白的活化.结论 基于网络药理学研究显示金花清感颗粒具有多靶点、多通路协同作用发挥药效的特点,通过体外细胞试验进一步验证显示金花清感颗粒通过抑制炎症细胞模型iNOS表达和NF-κB与MAPK信号通路的激活干预炎症细胞因子释放,发挥抗炎活性,该结果为深入研究金花清感颗粒作用机制及临床应用提供理论依据.
Study and Verification of Anti-inflammatory Mechanism of Jinhua Qinggan Granules Based on Network Pharmacology
Objective To evaluate and explore the anti-inflammatory activity and mechanisms of Jinhua Qinggan Granules based on network pharmacology and in vitro cellular experiments,in order to provide theoretical basis for its clinical application.Methods TCMSP,Pubchem database and related literature were utilized to screen out the active ingredients and targets of Jinhua Qinggan Granules.The associated targets of influenza,headache,fever,and cough were screened through NCBI and GenCards databases,and comparative analyses with the above ingredient-targets were carried out in order to screen out the core targets.Cytoscape 3.7.2 software was used to generate the network diagram,and finally,GO and KEGG enrichment analyses of the key targets were conducted by Metascape database.In vitro cellular assays were performed using the lipopolysaccharide(LPS)-induced RAW264.7 inflammatory cell model.The effect of the extract of Jinhua Qinggan Granules on the secretion of nitric oxide(NO)was detected by Griess method,and the effects of the extract on the RNA and protein levels of key targets in RAW264.7 cells were determined by quantitative real-time polymerase chain reaction(qRT-PCR)and Western blotting,respectively.Results A total of 278 active ingredients and 1316 potential targets were identified,including 1065 disease-related targets,which were mainly related to the mitogen-activated protein kinase(MAPK)signaling pathway,the nuclear factor-κB(NF-κB)signaling pathway,and the neuroactive ligand-receptor interaction signaling pathway.The results of in vitro cellular experiments showed that compared with the LPS-stimulated group,the aqueous extract of Jinhua Qinggan Granules significantly reduced the secretion of NO in LPS-induced RAW264.7 cells at the concentration of 200,400 and 800 μg/ml(P<0.01).The qRT-PCR assay revealed that Jinhua Qinggan Granules extract could obviously inhibit the mRNA levels of inducible nitric oxide synthase(iNOS),cyclooxygenase-2(COX-2),and interleukin 6(IL-6)in LPS-induced RAW264.7 cells(P<0.01).Western blotting assay revealed that the extract of Jinhua Qinggan Granules could inhibit the expression of iNOS and the activation of key proteins in the NF-κB and MAPK signaling pathways.Conclusion Based on the network pharmacology study,Jinhua Qinggan Granules has the characteristics of multi-target and multi-pathway synergistic effect,and further in vitro cellular experiments show that Jinhua Qinggan Granules exert anti-inflammatory activity by inhibition of the expression of iNOS and the activation of NF-κB and MAPK signaling pathways to intervene in the release of inflammatory cytokines in the inflammatory cell model.The results provide a theoretical basis for the clinical application of Jinhua Qinggan Granules.

Jinhua Qinggan Granulesnetwork pharmacologyanti-inflammationmolecular mechanism

陈启梅、杨静依、付林婷、王安美、孙艺轩、张加余、杨爱琳、魏霞

展开 >

滨州医学院 药学院,山东 烟台 264003

山东省食品药品检验研究院,山东 济南 250010

金花清感颗粒 网络药理学 抗炎 分子机制

国家自然科学基金项目山东省泰山学者青年专家项目烟台市省级以上领军人才配套项目滨州医学院新冠培育专项滨州医学院高层次人才引进计划

82204693tsqn20210311010073801BY2021XGFY03BY2020KYQD13

2024

食品与药品
山东省生物药物研究院

食品与药品

CSTPCD
影响因子:0.537
ISSN:1672-979X
年,卷(期):2024.26(2)
  • 23